PLATFORM OVERVIEW

Bionanotechnology and microfluidics provide the foundations for GeneFluidics' testing platform. Our use of bionanotechnology drives high signal to noise ratios (sensitivity), while the incorporation of microfluidics permits operational simplicity. More specifically, the ultra-sensitivity of our electrochemical detection module, embodied in plastic sensor chips and a reader instrument, is enabled by proprietary nanometer scale sensor surface treatments. In contrast, the simplicity of our automated sample preparation module, embodied in disposable cartridges and instrument-based fluidic handling components, is made possible through our use of novel injection-molded microfluidic structures.

Latest News:

Sept 12, 2007 GeneFluidics is funded to advance the rapid antibiotics resistance screening test with VA/UCLA hospital and ASU

Jan 1, 2007 Saliva diagnostics made possible with GeneFluidics' technology

Non-Invasive Health Screening with Saliva

October 17, 2006 GeneFluidics is awarded to advance saliva diagnostics through a $15 Million NIH project.

February 2, 2006 UCLA / VA study demonstrates the rapid diagnosis of Urinary Track Infections with novel biosensor technology

UTI Video Release (High Resolution)

August 8, 2005 GeneFluidics, Inc. Announces Collaboration with the Shanghai Institute of Applied Physics, Chinese Academy of Sciences